Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.

@article{Andreadou2017RhamnolipidsMV,
  title={Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.},
  author={Eleni G. Andreadou and Anastasia A Pantazaki and Makrina Daniilidou and Magda Tsolaki},
  journal={Journal of Alzheimer's disease : JAD},
  year={2017},
  volume={59 1},
  pages={
          209-222
        }
}
Alzheimer's disease (AD) has been attributed to chronic bacterial infections. The recognition of human microbiota as a substantial contributor to health and disease is relatively recent and growing. During evolution, mammals live in a symbiotic state with myriads of microorganisms that survive at a diversity of tissue micro-surroundings. Microbes produce a plethora of secretory products [amyloids, lipopolysaccharides, virulence factors rhamnolipids (RLs), toxins, and a great number of… 

Figures and Tables from this paper

Bacterial rhamnolipids (RLs) in saliva of Alzheimer's disease and Mild Cognitive Impairment patients and correlation with neuroinflammation and cognitive state

Investigating RLs levels in saliva of Mild Cognitive Impairment and AD patients with indirect ELISA indicates that RLs could be suggested as eventual biomarkers for AD diagnosis using saliva as biological fluid.

Iron Dysregulation and Dormant Microbes as Causative Agents for Impaired Blood Rheology and Pathological Clotting in Alzheimer’s Type Dementia

This hypothesis is consistent with current literature in which serum ferritin levels of individuals diagnosed with Alzheimer’s disease are significantly higher compared those of age- and gender-matched controls, and with the Iron Dysregulation and Dormant Microbes hypothesis, previously put forward.

Alzheimer’s disease and gastrointestinal microbiota; impact of Helicobacter pylori infection involvement

A systematic review of PubMed/MEDLINE database showed a possible association between AD and gastrointestinal microbiota mainly including Helicobacter pylori, and thus further research is required for substantiation of causality as well as for the establishment of promising novel therapies.

Inflammation in CNS neurodegenerative diseases

A better understanding of neuroimmune interactions during development and disease will be key to further manipulating these responses and the development of effective therapies to improve quality of life, and reduce the impact of neuroinflammatory and degenerative diseases.

Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-/PR- breast cancer cells

An inverse correlation between PAI-1 and ESR1/PGR levels, as well as overall patient survival in estrogen/progesterone-responsive human tumours, is demonstrated.

The Role of Pseudomonas aeruginosa Virulence Factors in Cytoskeletal Dysregulation and Lung Barrier Dysfunction

This review summarizes the current knowledge on P. aeruginosa virulence factors, their effects on the regulation of the cytoskeletal network and associated components, and molecular mechanisms regulating barrier function in airway epithelial and endothelial cells.

Tissue Microbiome Associated With Human Diseases by Whole Transcriptome Sequencing and 16S Metagenomics

This review aims to summarize the studies that associate the tissue microbiome, rather than gut microbiome, with cancer and other diseases using whole-transcriptome analysis, along with 16S rRNA analysis.

The intestinal microbiome and its relevance for functionality in older persons

The intestinal microbiome composition represents a possible determinant of functional performance in older people, and a promising target for antiaging therapeutic interventions.

Microbiota-Brain-Gut Axis and Neurodegenerative Diseases

  • E. Quigley
  • Biology, Medicine
    Current Neurology and Neuroscience Reports
  • 2017
In theory, a role for the microbiota-gut-brain axis is highly plausible; clinical confirmation is awaited and a theoretical basis can be developed for the use of microbiota-directed therapies in neurodegenerative disorders.

References

SHOWING 1-10 OF 89 REFERENCES

Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer's disease brain tissue.

It is confirmed that LPS from periodontal bacteria can access the AD brain during life as labeling in the corresponding controls, with equivalent/longer postmortem interval, was absent.

Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer’s Disease (AD)

This general commentary-perspective paper will highlight some recent findings on microbial-derived secreted LPS and amyloids and the potential contribution of these neurotoxic and proinflammatory microbial exudates to age-related inflammatory amyloidogenesis and neurodegeneration, with specific reference to AD wherever possible.

Emerging roles of pathogens in Alzheimer disease

  • J. Miklossy
  • Biology
    Expert Reviews in Molecular Medicine
  • 2011
Aβ has been shown to be a pore-forming antimicrobial peptide, indicating that Aβ accumulation might be a response to infection, and dementia might be prevented by combined antibiotic, antiviral and anti-inflammatory therapy.

A Bacterial Component to Alzheimer’s-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease

This integrative systems approach has strong predictive power, indicating (as has indeed been shown) that both natural and pharmaceutical iron chelators might have useful protective roles in arresting cognitive decline, and that a further assessment of the role of microbes in AD development is more than highly warranted.

Development of an Antibody for Detection of Rhamnolipids Characterized as a Major Bacterial Virulence Factor

The development of this antibody is addressed in detail, as the sensitive analytical technique, and its potential use would facilitate the implementation of rhamnolipids’ detection, or may be a useful and promising tool for determining these microbial secondary metabolites and virulence factors secreted in extracellular culture media or in biological fluids during infections.

Rhamnolipids Are Virulence Factors That Promote Early Infiltration of Primary Human Airway Epithelia by Pseudomonas aeruginosa

The study provides direct evidence for a hitherto unknown mechanism whereby the junction-dependent barrier of the respiratory epithelium is selectively altered by rhamnolipid-deficient P. aeruginosa.

Iron Dysregulation and Dormant Microbes as Causative Agents for Impaired Blood Rheology and Pathological Clotting in Alzheimer’s Type Dementia

This hypothesis is consistent with current literature in which serum ferritin levels of individuals diagnosed with Alzheimer’s disease are significantly higher compared those of age- and gender-matched controls, and with the Iron Dysregulation and Dormant Microbes hypothesis, previously put forward.

[Alzheimer's disease: the infectious hypothesis].

E Epidemiological and experimental studies on cellular or murine models related to herpes simplex virus, spirochetes, Chlamydia pneumoniae or Borrelia, and systemic inflammation are reviewed, suggesting a role of infectious agents in AD neurodegeneration.

Alzheimer's disease—a spirochetosis?

Observations that in 14 autopsy cases with histopathologically confirmed AD, spirochetes were found in blood and cerebrospinal fluid and, moreover, could be isolated from brain tissue suggest that spiroChetes may be one of the causes of AD and that they may be the source of the β amyloid deposited in the AD brain.

On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death.

  • D. KellE. Pretorius
  • Biology
    Integrative biology : quantitative biosciences from nano to macro
  • 2015
The bacterial requirement for free iron explains the strong co-existence in these diseases of iron dysregulation, LPS production, and inflammation through the centrality of a dormant blood microbiome that can resuscitate and shed cell wall components.
...